A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis
Clinical trial NCT06989567 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06989567
- Sponsor
- Asklepion Pharmaceuticals, LLC
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-25
- Primary completion
- 2027-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.